StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1037.HK$0.63+1.61%
Fair $0.63+0.0%

1037.HK

Maxnerva Technology Services Limited

Technology / Information Technology ServicesHKSE

$0.63

+0.01 (+1.61%)

Fairly Valued+0.0%Fair Value $0.63Fund rank 28/100 · Data gapFallback financials|
SA 31/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-1.3M · quality 48.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 19/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -3.6%, below the 5% threshold
Thesis & Journal · 1037.HKLocal privado en este navegador · Maxnerva Technology Services Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$445M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-3.6%

↓

Gross Margin

14.9%

↓

Debt/Equity

0.02

↓
52-Week Range$1
$0$1

TradingView lightweight chart

1037.HK price, volumen y niveles de valoración

Último $0.630Periodo +22.6%
Fair value: $0.630

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-5.3%

FCF CAGR

—

FCF margin

-9.7%

FCF / Net income

4.74x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $707.6M · net income $-14.6M · FCF $-68.9M

2022-FY → 2025-FY

Gross margin

14.9%-0.4% pts

Operating margin

2.8%-0.3% pts

Net margin

-2.1%-5.4% pts

FCF margin

-9.7%-12.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$707.6M$707.6M$558.9M$677.9M$832.5M
Net Income$-14.6M$-14.6M$-12.4M$-16.8M$27.8M
EBITDA$-170000.00$-170000.00$1.1M$1.6M$50.2M
EPS-0.02-0.02-0.02-0.020.04
Gross Margin14.9%14.9%15.7%14.3%15.3%
Operating Margin2.8%2.8%0.8%0.1%3.1%
Net Margin-2.1%-2.1%-2.2%-2.5%3.3%
Balance Sheet
Debt/Equity0.020.020.020.010.02
Current Ratio2.752.75———
Cash Flow
Free Cash Flow$-68.9M$-68.9M$-1.3M$31.2M$20.3M
Returns
ROE-3.6%-3.6%-2.9%-3.9%6.2%
Valuation
P/E————5.97
EV/EBITDA——1.60-38.040.18
P/B1.091.090.420.280.37
Growth & Yield
Revenue Growth26.6%26.6%-17.5%-18.6%—
EPS Growth-16.9%-16.9%26.3%-160.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +153.0%

Total return

+153.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.02 → -0.02

Residual

+153.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+153.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.